Roche to begin Phase III of personalised MetMab treatment in NSCLC
19 May 2011
Pial Ganguli
Please Login to read the full article.
19 May 2011
Pial Ganguli
Please Login to read the full article.
RELATED CONTENT
NEWS
- Chugai takes on two more Roche personalised medicine projects for Japan
- Peregrine rises on "robust" Phase IIb second-line NSCLC data
- Idera holds out hope for IMO-2055 after negative Phase II head and neck cancer data
- AVEO's unconvincing Phase II ficlatuzumab data point to need for further studies
ANALYSIS
Other Informa Analysis
FEATURES
Other Informa Features
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
